Publikationen (34) Publikationen, an denen Forscher/innen teilgenommen haben

2018

  1. A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study

    Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704

  2. A risk-adapted approach to patients with stage i seminoma according to the status of rete testis: The fourth Spanish germ cell cancer group study

    Oncology (Switzerland), Vol. 95, Núm. 1, pp. 8-12

  3. Altered red blood cell membrane fatty acid profile in cancer patients

    Nutrients, Vol. 10, Núm. 12

  4. Aportación del uso medicinal de los derivados del cannabis: una revisión de su potencial eficacia clínica y riesgos

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 115, Núm. 2, pp. 83-95

  5. Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment

    Supportive Care in Cancer, Vol. 26, Núm. 12, pp. 4077-4086

  6. Augmenting guideline knowledge with non-compliant clinical decisions: Experience-based decision support

    Smart Innovation, Systems and Technologies

  7. Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: A systematic review

    Oncotarget, Vol. 9, Núm. 32, pp. 22850-22861

  8. Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: Pooled analysis in 4 basque country university hospitals

    ClinicoEconomics and Outcomes Research, Vol. 10, pp. 189-199

  9. Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

    BMC Cancer, Vol. 18, Núm. 1

  10. Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/ HER2-negative breast cancer-the evaluating treatment with neoadjuvant abraxane (ETNA) trial a randomized phase 3 clinical trial

    JAMA Oncology, Vol. 4, Núm. 3, pp. 302-308

  11. Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS

    Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1261-1267

  12. Contribution of the medicinal use of cannabis derivatives: A review of their potential clinical efficacy and risks

    Gaceta Medica de Bilbao, Vol. 115, Núm. 2, pp. 83-95

  13. Cost-effectiveness analysis of laparoscopic versus open surgery in colon cancer

    Surgical Endoscopy, Vol. 32, Núm. 12, pp. 4912-4922

  14. Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/ HER2– advanced or metastatic breast cancer in Spain

    ClinicoEconomics and Outcomes Research, Vol. 10, pp. 773-790

  15. Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis

    Journal of Geriatric Oncology, Vol. 9, Núm. 3, pp. 254-264

  16. Final results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin & chemo-radiation in stage III NSCLC - SLCG 10/02

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii490

  17. First analysis of patients (p) with stage IV non-small cell lung cancer (NSCLC) of the thoracic tumor registry (RTT) of the Spanish Lung Cancer Group (SLCG)

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii535-viii536

  18. Indirect costs associated with glioblastoma: Experience at one hospital

    Neurologia, Vol. 33, Núm. 2, pp. 121-128

  19. Infective endocarditis in a patient with metastatic colorectal cancer

    Revista Espanola de Quimioterapia

  20. Internal Carotid Artery Web as the Cause of Recurrent Cryptogenic Ischemic Stroke

    Journal of Stroke and Cerebrovascular Diseases, Vol. 27, Núm. 5, pp. e86-e87